1. Indelicato JM, Pasini CE.. (1988) The acylating potential of gamma-lactam antibacterials: base hydrolysis of bicyclic pyrazolidinones., 31 (6): [PMID:3373491] [10.1021/jm00401a026] |
2. Tsuji K, Ishikawa H. (1994) Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7, 4 (13): [10.1016/S0960-894X(01)80574-6] |
3. Curran WV, Lenhard RH.. (1989) N-azamonobactams. 2. Synthesis of some N-iminoacetic acid and N-glycyl analogues., 32 (8): [PMID:2754701] [10.1021/jm00128a014] |
4. Brickner SJ, Gaikema JJ, Greenfield LJ, Zurenko GE, Manninen PR. (1993) N-acyl-3-alkylidenyl- and 3-alkyl azeitidin-2-ones: a new class of monocyclic -lactam antibacterial agents 2. Synthesis and structure-activity relationships of heteroatom substituted 3-isopropylidene and 3-isopropyl analogs, 3 (11): [10.1016/S0960-894X(01)80932-X] |
5. Boyd DB, Eigenbrot C, Indelicato JM, Miller MJ, Pasini CE, Woulfe SR.. (1987) Heteroatom-activated beta-lactam antibiotics: considerations of differences in the biological activity of [[3(S)-(acylamino)-2-oxo-1-azetidinyl]oxy]acetic acids (oxamazins) and the corresponding sulfur analogues (thiamazins)., 30 (3): [PMID:3820225] [10.1021/jm00386a015] |
6. Liang CH, Romero A, Rabuka D, Sgarbi PW, Marby KA, Duffield J, Yao S, Cheng ML, Ichikawa Y, Sears P, Hu C, Hwang SB, Shue YK, Sucheck SJ.. (2005) Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities., 15 (8): [PMID:15808482] [10.1016/j.bmcl.2005.02.029] |
7. Poirel L, Cattoir V, Soares A, Soussy CJ, Nordmann P.. (2007) Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1., 51 (2): [PMID:17116662] [10.1128/aac.01082-06] |
8. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ.. (2007) Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China., 51 (2): [PMID:17145797] [10.1128/aac.01053-06] |
9. Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt LA.. (2007) Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance., 51 (2): [PMID:17158943] [10.1128/aac.00851-06] |
10. Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L.. (2007) Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis., 51 (3): [PMID:17158942] [10.1128/aac.00954-06] |
11. Doi Y, de Oliveira Garcia D, Adams J, Paterson DL.. (2007) Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil., 51 (3): [PMID:17158944] [10.1128/aac.01345-06] |
12. Mazzariol A, Roelofsen E, Koncan R, Voss A, Cornaglia G.. (2007) Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands., 51 (3): [PMID:17178800] [10.1128/aac.00909-06] |
13. Robin F, Delmas J, Schweitzer C, Tournilhac O, Lesens O, Chanal C, Bonnet R.. (2007) Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient., 51 (4): [PMID:17220412] [10.1128/aac.01058-06] |
14. Wu JJ, Ko WC, Tsai SH, Yan JJ.. (2007) Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital., 51 (4): [PMID:17242140] [10.1128/aac.01195-06] |
15. Naas T, Aubert D, Ozcan A, Nordmann P.. (2007) Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii., 51 (4): [PMID:17242148] [10.1128/aac.01152-06] |
16. Reinhardt A, Köhler T, Wood P, Rohner P, Dumas JL, Ricou B, van Delden C.. (2007) Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients., 51 (4): [PMID:17261619] [10.1128/aac.01278-06] |
17. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, Colombian Nosocomial Resistance Study Group.. (2007) First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase., 51 (4): [PMID:17261621] [10.1128/aac.01405-06] |
18. Yoshida K, Nakayama K, Ohtsuka M, Kuru N, Yokomizo Y, Sakamoto A, Takemura M, Hoshino K, Kanda H, Nitanai H, Namba K, Yoshida K, Imamura Y, Zhang JZ, Lee VJ, Watkins WJ.. (2007) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate., 15 (22): [PMID:17869116] [10.1016/j.bmc.2007.07.039] |
19. Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M.. (2007) Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal., 51 (6): [PMID:17371815] [10.1128/aac.01412-06] |
20. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T.. (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment., 51 (6): [PMID:17387156] [10.1128/aac.01509-06] |
21. Endimiani A, Luzzaro F, Migliavacca R, Mantengoli E, Hujer AM, Hujer KM, Pagani L, Bonomo RA, Rossolini GM, Toniolo A.. (2007) Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase., 51 (6): [PMID:17404005] [10.1128/aac.01139-06] |
22. Peña C, Guzmán A, Suarez C, Dominguez MA, Tubau F, Pujol M, Gudiol F, Ariza J.. (2007) Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients., 51 (6): [PMID:17420207] [10.1128/aac.01483-06] |
23. Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, Faccone D, Galas M, Drugeon H, Cattoir V, Nordmann P.. (2007) Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina., 51 (6): [PMID:17420213] [10.1128/aac.01600-06] |
24. Papagiannitsis CC, Loli A, Tzouvelekis LS, Tzelepi E, Arlet G, Miriagou V.. (2007) SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli., 51 (6): [PMID:17353248] [10.1128/aac.01439-06] |
25. Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson MO, Couetdic G, Plésiat P.. (2007) Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections., 51 (10): [PMID:17682106] [10.1128/aac.00503-07] |
26. Papagiannitsis CC, Tzouvelekis LS, Tzelepi E, Miriagou V.. (2007) Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli., 51 (10): [PMID:17664321] [10.1128/aac.00389-07] |
27. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P.. (2007) Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland., 51 (8): [PMID:17470647] [10.1128/aac.01614-06] |
28. Ikonomidis A, Labrou M, Afkou Z, Maniatis AN, Sofianou D, Tsakris A, Pournaras S.. (2007) First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12., 51 (8): [PMID:17517838] [10.1128/aac.00374-07] |
29. Bae IK, Lee YN, Lee WG, Lee SH, Jeong SH.. (2007) Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene., 51 (8): [PMID:17517851] [10.1128/aac.00279-07] |
30. Chen YT, Lauderdale TL, Liao TL, Shiau YR, Shu HY, Wu KM, Yan JJ, Su IJ, Tsai SF.. (2007) Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae., 51 (8): [PMID:17526756] [10.1128/aac.00167-07] |
31. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y.. (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital., 51 (8): [PMID:17562800] [10.1128/aac.00299-07] |
32. Perilli M, Caporale B, Celenza G, Pellegrini C, Docquier JD, Mezzatesta M, Rossolini GM, Stefani S, Amicosante G.. (2007) Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes., 51 (8): [PMID:17470648] [10.1128/aac.00083-07] |
33. Vinks AA, van Rossem RN, Mathôt RA, Heijerman HG, Mouton JW.. (2007) Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation., 51 (9): [PMID:17576827] [10.1128/aac.01522-06] |
34. Kroeger LA, Hovde LB, Mitropoulos IF, Schafer J, Rotschafer JC.. (2007) Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model., 51 (9): [PMID:17576842] [10.1128/aac.01433-06] |
35. Quinteira S, Grosso F, Ramos H, Peixe L.. (2007) Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital., 51 (9): [PMID:17606684] [10.1128/aac.00267-07] |
36. Pérez A, Canle D, Latasa C, Poza M, Beceiro A, Tomás Mdel M, Fernández A, Mallo S, Pérez S, Molina F, Villanueva R, Lasa I, Bou G.. (2007) Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate., 51 (9): [PMID:17638702] [10.1128/aac.00072-07] |
37. Girlich D, Leclercq R, Naas T, Nordmann P.. (2007) Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii., 51 (11): [PMID:17846134] [10.1128/aac.00537-07] |
38. Neuwirth C, Siebor E, Robin F, Bonnet R.. (2007) First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France., 51 (12): [PMID:17938180] [10.1128/aac.01462-06] |
39. Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF.. (2007) An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii., 51 (11): [PMID:17724156] [10.1128/aac.01512-06] |
40. Fonseca F, Sarmento AC, Henriques I, Samyn B, van Beeumen J, Domingues P, Domingues MR, Saavedra MJ, Correia A.. (2007) Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase., 51 (12): [PMID:17875998] [10.1128/aac.00491-07] |
41. Robin F, Delmas J, Brebion A, Dubois D, Constantin JM, Bonnet R.. (2007) TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases., 51 (11): [PMID:17709463] [10.1128/aac.00614-07] |
42. Toleman MA, Vinodh H, Sekar U, Kamat V, Walsh TR.. (2007) blaVIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3' conserved sequence., 51 (7): [PMID:17438051] [10.1128/aac.01043-06] |
43. Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A.. (2007) Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents., 51 (7): [PMID:17470655] [10.1128/aac.00174-07] |
44. Daikos GL, Kosmidis C, Tassios PT, Petrikkos G, Vasilakopoulou A, Psychogiou M, Stefanou I, Avlami A, Katsilambros N.. (2007) Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome., 51 (7): [PMID:17452479] [10.1128/aac.00044-07] |
45. Davies TA, Page MG, Shang W, Andrew T, Kania M, Bush K.. (2007) Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae., 51 (7): [PMID:17470659] [10.1128/aac.00029-07] |
46. Mendes RE, Castanheira M, Toleman MA, Sader HS, Jones RN, Walsh TR.. (2007) Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital., 51 (7): [PMID:17470660] [10.1128/aac.00838-06] |
47. Power P, Di Conza J, Rodríguez MM, Ghiglione B, Ayala JA, Casellas JM, Radice M, Gutkind G.. (2007) Biochemical characterization of PER-2 and genetic environment of blaPER-2., 51 (7): [PMID:17438050] [10.1128/aac.01395-06] |
48. Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A.. (2007) Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals., 51 (12): [PMID:17938181] [10.1128/aac.00810-07] |
49. Meziane-Cherif D, Decré D, Høiby EA, Courvalin P, Périchon B.. (2008) Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens., 52 (2): [PMID:18070972] [10.1128/aac.01145-07] |
50. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
51. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN.. (2008) Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program., 52 (2): [PMID:18070960] [10.1128/aac.01114-07] |
52. Zong Z, Partridge SR, Iredell JR.. (2008) RmtC 16S rRNA methyltransferase in Australia., 52 (2): [PMID:18025117] [10.1128/aac.01399-07] |
53. Cuzon G, Naas T, Demachy MC, Nordmann P.. (2008) Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece., 52 (2): [PMID:18056283] [10.1128/aac.01180-07] |
54. Baussanne I, Bussière A, Halder S, Ganem-Elbaz C, Ouberai M, Riou M, Paris JM, Ennifar E, Mingeot-Leclercq MP, Décout JL.. (2010) Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives., 53 (1): [PMID:20000576] [10.1021/jm900615h] |
55. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
56. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
57. Guerra A, Campillo NE, Páez JA.. (2010) Neural computational prediction of oral drug absorption based on CODES 2D descriptors., 45 (3): [PMID:20022146] [10.1016/j.ejmech.2009.11.034] |
58. Girlich D, Poirel L, Nordmann P.. (2010) First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate., 54 (1): [PMID:19884362] [10.1128/aac.00861-09] |
59. Poirel L, Docquier JD, De Luca F, Verlinde A, Ide L, Rossolini GM, Nordmann P.. (2010) BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa., 54 (1): [PMID:19884378] [10.1128/aac.00859-09] |
60. Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L.. (2010) VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae., 54 (1): [PMID:19917750] [10.1128/aac.00458-09] |
61. Suh JY, Son JS, Chung DR, Peck KR, Ko KS, Song JH.. (2010) Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea., 54 (1): [PMID:19752282] [10.1128/aac.00762-09] |
62. Coyne S, Guigon G, Courvalin P, Périchon B.. (2010) Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray., 54 (1): [PMID:19884373] [10.1128/aac.01037-09] |
63. Girlich D, Poirel L, Nordmann P.. (2010) Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France., 54 (1): [PMID:19901091] [10.1128/aac.00961-09] |
64. Doublet B, Robin F, Casin I, Fabre L, Le Fleche A, Bonnet R, Weill FX.. (2010) Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola., 54 (1): [PMID:19884377] [10.1128/aac.00427-09] |
65. Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R.. (2010) Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria., 54 (1): [PMID:19901092] [10.1128/aac.00017-09] |
66. King P, Lomovskaya O, Griffith DC, Burns JL, Dudley MN.. (2010) In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis., 54 (1): [PMID:19805554] [10.1128/aac.00248-09] |
67. Juan C, Zamorano L, Pérez JL, Ge Y, Oliver A, Spanish Group for the Study of Pseudomonas, Spanish Network for Research in Infectious Diseases.. (2010) Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains., 54 (2): [PMID:19933793] [10.1128/aac.00834-09] |
68. Moya B, Zamorano L, Juan C, Pérez JL, Ge Y, Oliver A.. (2010) Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients., 54 (3): [PMID:20086158] [10.1128/aac.01104-09] |
69. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP.. (2010) Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations., 54 (3): [PMID:20028819] [10.1128/aac.00963-09] |
70. Kotsakis SD, Papagiannitsis CC, Tzelepi E, Legakis NJ, Miriagou V, Tzouvelekis LS.. (2010) GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa., 54 (3): [PMID:20065056] [10.1128/aac.01561-09] |
71. Guillon H, Eb F, Mammeri H.. (2010) Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena., 54 (5): [PMID:20308380] [10.1128/aac.00791-09] |
72. Endimiani A, Bethel C, Choudhary Y, Bonomo RA.. (2010) In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates., 54 (4): [PMID:20124003] [10.1128/aac.01821-09] |
73. Nishino K, Yamasaki S, Hayashi-Nishino M, Yamaguchi A.. (2010) Effect of NlpE overproduction on multidrug resistance in Escherichia coli., 54 (5): [PMID:20211889] [10.1128/aac.01677-09] |
74. Hu RM, Huang KJ, Wu LT, Hsiao YJ, Yang TC.. (2008) Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia., 52 (3): [PMID:18086856] [10.1128/aac.00682-07] |
75. Cai JC, Zhou HW, Zhang R, Chen GX.. (2008) Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital., 52 (6): [PMID:18332176] [10.1128/aac.01539-07] |
76. Marchiaro P, Tomatis PE, Mussi MA, Pasteran F, Viale AM, Limansky AS, Vila AJ.. (2008) Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain., 52 (6): [PMID:18362187] [10.1128/aac.01025-07] |
77. Doi Y, Poirel L, Paterson DL, Nordmann P.. (2008) Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans., 52 (6): [PMID:18362192] [10.1128/aac.01463-07] |
78. Davies TA, Shang W, Bush K, Flamm RK.. (2008) Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa., 52 (4): [PMID:18250190] [10.1128/aac.01529-07] |
79. Mendonça N, Manageiro V, Bonnet R, Caniça M.. (2008) Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae., 52 (5): [PMID:18316524] [10.1128/aac.01525-07] |
80. de Oliveira Garcia D, Doi Y, Szabo D, Adams-Haduch JM, Vaz TM, Leite D, Padoveze MC, Freire MP, Silveira FP, Paterson DL.. (2008) Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil., 52 (5): [PMID:18347108] [10.1128/aac.01440-07] |
81. Poirel L, Rodríguez-Martínez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P.. (2010) Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands., 54 (6): [PMID:20308383] [10.1128/aac.01456-09] |
82. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK.. (2010) Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan., 54 (6): [PMID:20368407] [10.1128/aac.01624-09] |
83. Loli A, Tzouvelekis LS, Gianneli D, Tzelepi E, Miriagou V.. (2008) Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests., 52 (5): [PMID:18285473] [10.1128/aac.01414-07] |
84. Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, Honderlick P, Nordmann P.. (2010) Spread of OXA-48-encoding plasmid in Turkey and beyond., 54 (3): [PMID:20086157] [10.1128/aac.01312-09] |
85. De Luca F, Giraud-Morin C, Rossolini GM, Docquier JD, Fosse T.. (2010) Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes., 54 (4): [PMID:20124004] [10.1128/aac.01252-09] |
86. Perilli M, Celenza G, De Santis F, Pellegrini C, Forcella C, Rossolini GM, Stefani S, Amicosante G.. (2008) E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates., 52 (3): [PMID:18160520] [10.1128/aac.01028-07] |
87. Page MG, Dantier C, Desarbre E.. (2010) In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli., 54 (6): [PMID:20308379] [10.1128/aac.01525-09] |
88. Mendonça N, Manageiro V, Robin F, Salgado MJ, Ferreira E, Caniça M, Bonnet R.. (2008) The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition., 52 (5): [PMID:18316518] [10.1128/aac.01381-07] |
89. Poirel L, Mansour W, Bouallegue O, Nordmann P.. (2008) Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97., 52 (5): [PMID:18299404] [10.1128/aac.00978-07] |
90. San Millan A, Garcia-Cobos S, Escudero JA, Hidalgo L, Gutierrez B, Carrilero L, Campos J, Gonzalez-Zorn B.. (2010) Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination., 54 (4): [PMID:20086141] [10.1128/aac.01489-09] |
91. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P.. (2008) Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene., 52 (4): [PMID:18227185] [10.1128/aac.01451-07] |
92. Tomás M, Doumith M, Warner M, Turton JF, Beceiro A, Bou G, Livermore DM, Woodford N.. (2010) Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients., 54 (5): [PMID:20194693] [10.1128/aac.00816-09] |
93. Yoneyama H, Akiba K, Hori H, Ando T, Nakae T.. (2010) Tat pathway-mediated translocation of the sec pathway substrate protein MexA, an inner membrane component of the MexAB-OprM xenobiotic extrusion pump in Pseudomonas aeruginosa., 54 (4): [PMID:20100880] [10.1128/aac.01495-09] |
94. Meziane-Cherif D, Lambert T, Dupêchez M, Courvalin P, Galimand M.. (2008) Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442., 52 (4): [PMID:18212108] [10.1128/aac.00684-07] |
95. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, Song JH, Ko KS.. (2010) KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea., 54 (5): [PMID:20211897] [10.1128/aac.00011-10] |
96. Endimiani A, Carias LL, Hujer AM, Bethel CR, Hujer KM, Perez F, Hutton RA, Fox WR, Hall GS, Jacobs MR, Paterson DL, Rice LB, Jenkins SG, Tenover FC, Bonomo RA.. (2008) Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States., 52 (7): [PMID:18426899] [10.1128/aac.00158-08] |
97. Bush K, Jacoby GA.. (2010) Updated functional classification of beta-lactamases., 54 (3): [PMID:19995920] [10.1128/aac.01009-09] |
98. Manageiro V, Ferreira E, Albuquerque L, Bonnet R, Caniça M.. (2010) Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain., 54 (5): [PMID:20211886] [10.1128/aac.01442-09] |
99. Chen TL, Wu RC, Shaio MF, Fung CP, Cho WL.. (2008) Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii., 52 (7): [PMID:18443121] [10.1128/aac.00393-08] |
100. Jeannot K, Elsen S, Köhler T, Attree I, van Delden C, Plésiat P.. (2008) Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump., 52 (7): [PMID:18474583] [10.1128/aac.01107-07] |
101. Schneider I, Keuleyan E, Rasshofer R, Markovska R, Queenan AM, Bauernfeind A.. (2008) VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany., 52 (8): [PMID:18519714] [10.1128/aac.00175-08] |
102. Stoczko M, Frère JM, Rossolini GM, Docquier JD.. (2008) Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora., 52 (7): [PMID:18443127] [10.1128/aac.01062-07] |
103. Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P.. (2008) Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey., 52 (8): [PMID:18519712] [10.1128/aac.01672-07] |
104. Garza-Ramos U, Morfin-Otero R, Sader HS, Jones RN, Hernández E, Rodriguez-Noriega E, Sanchez A, Carrillo B, Esparza-Ahumada S, Silva-Sanchez J.. (2008) Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico., 52 (8): [PMID:18490501] [10.1128/aac.00679-07] |
105. Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y.. (2008) Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates., 52 (8): [PMID:18519713] [10.1128/aac.01341-07] |
106. Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W.. (2008) Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France., 52 (10): [PMID:18625772] [10.1128/aac.00163-08] |
107. Shin YP, Park HJ, Shin SH, Lee YS, Park S, Jo S, Lee YH, Lee IH.. (2010) Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases., 54 (7): [PMID:20385874] [10.1128/aac.01790-09] |
108. Samuelsen Ø, Castanheira M, Walsh TR, Spencer J.. (2008) Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family., 52 (8): [PMID:18559652] [10.1128/aac.00166-08] |
109. Sugimura M, Maseda H, Hanaki H, Nakae T.. (2008) Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa., 52 (11): [PMID:18676884] [10.1128/aac.00511-08] |
110. Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, Perilli M, Pollini S, Spalla M, Amicosante G, Toniolo A, Pagani L.. (2008) First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy., 52 (11): [PMID:18809945] [10.1128/aac.00707-08] |
111. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S.. (2010) Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel., 54 (7): [PMID:20350950] [10.1128/aac.01818-09] |
112. Mammeri H, Galleni M, Nordmann P.. (2009) Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli., 53 (1): [PMID:19001118] [10.1128/aac.00608-08] |
113. Cattoir V, Poirel L, Nordmann P.. (2008) Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France., 52 (10): [PMID:18644958] [10.1128/aac.00638-08] |
114. Dubois V, Poirel L, Demarthe F, Arpin C, Coulange L, Minarini LA, Bezian MC, Nordmann P, Quentin C.. (2008) Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae., 52 (10): [PMID:18663019] [10.1128/aac.00387-08] |
115. Rodríguez MM, Power P, Sader H, Galleni M, Gutkind G.. (2010) Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup., 54 (7): [PMID:20421403] [10.1128/aac.01615-09] |
116. Valenza G, Joseph B, Elias J, Claus H, Oesterlein A, Engelhardt K, Turnwald D, Frosch M, Abele-Horn M, Schoen C.. (2010) First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital., 54 (8): [PMID:20498315] [10.1128/aac.00080-10] |
117. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC.. (2009) First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil., 53 (1): [PMID:19015350] [10.1128/aac.00736-08] |
118. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Huang TD, Nordmann P.. (2008) Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium., 52 (9): [PMID:18644970] [10.1128/aac.00543-08] |
119. Juan C, Beceiro A, Gutiérrez O, Albertí S, Garau M, Pérez JL, Bou G, Oliver A.. (2008) Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain., 52 (10): [PMID:18644957] [10.1128/aac.00465-08] |
120. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martínez-Martínez L.. (2009) Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog., 53 (1): [PMID:19001117] [10.1128/aac.00896-08] |
121. Huang YW, Lin CW, Hu RM, Lin YT, Chung TC, Yang TC.. (2010) AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia., 54 (6): [PMID:20385866] [10.1128/aac.01283-09] |
122. Hocquet D, Plésiat P, Dehecq B, Mariotte P, Talon D, Bertrand X, ONERBA.. (2010) Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France., 54 (8): [PMID:20547814] [10.1128/aac.01646-09] |
123. Sekiguchi J, Morita K, Kitao T, Watanabe N, Okazaki M, Miyoshi-Akiyama T, Kanamori M, Kirikae T.. (2008) KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate., 52 (11): [PMID:18765691] [10.1128/aac.01337-07] |
124. Jolivette LJ, Ward KW.. (2005) Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure., 94 (7): [PMID:15920768] [10.1002/jps.20373] |
125. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
126. Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND.. (2009) Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4., 53 (2): [PMID:19015357] [10.1128/aac.00734-08] |
127. Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN.. (2009) Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18)., 53 (3): [PMID:19114677] [10.1128/aac.01011-08] |
128. Nagano Y, Nagano N, Wachino J, Ishikawa K, Arakawa Y.. (2009) Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime., 53 (1): [PMID:18955524] [10.1128/aac.00227-08] |
129. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM, Jones RN.. (2009) Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program., 53 (2): [PMID:19015330] [10.1128/aac.00999-08] |
130. Rodríguez-Martínez JM, Poirel L, Nordmann P.. (2009) Extended-spectrum cephalosporinases in Pseudomonas aeruginosa., 53 (5): [PMID:19258272] [10.1128/aac.01410-08] |
131. Almajan GL, Barbuceanu SF, Bancescu G, Saramet I, Saramet G, Draghici C.. (2010) Synthesis and antimicrobial evaluation of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives., 45 (12): [PMID:21036422] [10.1016/j.ejmech.2010.10.007] |
132. Jones CH, Ruzin A, Tuckman M, Visalli MA, Petersen PJ, Bradford PA.. (2009) Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155., 53 (3): [PMID:19075050] [10.1128/aac.01155-08] |
133. Poirel L, Rodriguez-Martinez JM, Plésiat P, Nordmann P.. (2009) Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex., 53 (3): [PMID:19075063] [10.1128/aac.00946-08] |
134. Zioga A, Whichard JM, Kotsakis SD, Tzouvelekis LS, Tzelepi E, Miriagou V.. (2009) CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids., 53 (3): [PMID:19104021] [10.1128/aac.01284-08] |
135. Sabet M, Miller CE, Nolan TG, Senekeo-Effenberger K, Dudley MN, Griffith DC.. (2009) Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa., 53 (9): [PMID:19528273] [10.1128/aac.00268-09] |
136. Giakkoupi P, Pappa O, Polemis M, Vatopoulos AC, Miriagou V, Zioga A, Papagiannitsis CC, Tzouvelekis LS.. (2009) Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases., 53 (9): [PMID:19581459] [10.1128/aac.00690-09] |
137. Picão RC, Poirel L, Gales AC, Nordmann P.. (2009) Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil., 53 (9): [PMID:19596871] [10.1128/aac.00453-09] |
138. Schneider I, Queenan AM, Markovska R, Markova B, Keuleyan E, Bauernfeind A.. (2009) New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria., 53 (10): [PMID:19620330] [10.1128/aac.00461-09] |
139. Zeba B, De Luca F, Dubus A, Delmarcelle M, Simporé J, Nacoulma OG, Rossolini GM, Frère JM, Docquier JD.. (2009) IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso., 53 (10): [PMID:19651915] [10.1128/aac.01607-08] |
140. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM.. (2009) Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone., 53 (10): [PMID:19687243] [10.1128/aac.00688-09] |
141. Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, Chaves F, Oliver A.. (2009) Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain., 53 (11): [PMID:19738007] [10.1128/aac.00900-09] |
142. Rodríguez-Martínez JM, Poirel L, Nordmann P.. (2009) Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa., 53 (11): [PMID:19738025] [10.1128/aac.00574-09] |
143. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR.. (2009) Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India., 53 (12): [PMID:19770275] [10.1128/aac.00774-09] |
144. Juan C, Mulet X, Zamorano L, Albertí S, Pérez JL, Oliver A.. (2009) Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain., 53 (12): [PMID:19770278] [10.1128/aac.00822-09] |
145. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H.. (2009) OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii., 53 (12): [PMID:19770279] [10.1128/aac.00856-09] |
146. Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L.. (2010) Extended-spectrum cephalosporinase in Acinetobacter baumannii., 54 (8): [PMID:20547808] [10.1128/aac.00050-10] |
147. Uemura S, Yokota S, Mizuno H, Sakawaki E, Sawamoto K, Maekawa K, Tanno K, Mori K, Asai Y, Fujii N.. (2010) Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient., 54 (9): [PMID:20566763] [10.1128/aac.00110-10] |
148. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE.. (2011) Prediction of drug intestinal absorption by new linear and non-linear QSPR., 46 (1): [PMID:21112128] [10.1016/j.ejmech.2010.11.005] |
149. Beceiro A, Pérez A, Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Vila J, Rodríguez-Baño J, Cisneros JM, Pachón J, Bou G, Spanish Group for Nosocomial Infection (GEIH).. (2009) Genetic variability among ampC genes from acinetobacter genomic species 3., 53 (3): [PMID:19029333] [10.1128/aac.00485-08] |
150. Duljasz W, Gniadkowski M, Sitter S, Wojna A, Jebelean C.. (2009) First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria., 53 (5): [PMID:19223629] [10.1128/aac.01573-08] |
151. Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC.. (2009) Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital., 53 (5): [PMID:19258268] [10.1128/aac.01355-08] |
152. Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.. (2009) Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients., 53 (5): [PMID:19258280] [10.1128/aac.01024-08] |
153. Asgarali A, Stubbs KA, Oliver A, Vocadlo DJ, Mark BL.. (2009) Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa., 53 (6): [PMID:19273679] [10.1128/aac.01617-08] |
154. Doublet B, Granier SA, Robin F, Bonnet R, Fabre L, Brisabois A, Cloeckaert A, Weill FX.. (2009) Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg., 53 (5): [PMID:19273683] [10.1128/aac.01581-08] |
155. Mandsberg LF, Ciofu O, Kirkby N, Christiansen LE, Poulsen HE, Høiby N.. (2009) Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system., 53 (6): [PMID:19332676] [10.1128/aac.00428-08] |
156. Vidaillac C, Leonard SN, Sader HS, Jones RN, Rybak MJ.. (2009) In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa., 53 (6): [PMID:19349512] [10.1128/aac.01452-08] |
157. Kitao T, Miyoshi-Akiyama T, Kirikae T.. (2009) AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates., 53 (6): [PMID:19349516] [10.1128/aac.01360-08] |
158. González-López JJ, Coelho A, Larrosa MN, Lavilla S, Bartolomé R, Prats G.. (2009) First detection of plasmid-encoded blaOXY beta-lactamase., 53 (7): [PMID:19380592] [10.1128/aac.01473-08] |
159. Potron A, Poirel L, Croizé J, Chanteperdrix V, Nordmann P.. (2009) Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii., 53 (7): [PMID:19380596] [10.1128/aac.01164-08] |
160. Doi Y, Paterson DL, Adams-Haduch JM, Sidjabat HE, O'Keefe A, Endimiani A, Bonomo RA.. (2009) Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase., 53 (7): [PMID:19414578] [10.1128/aac.00133-09] |
161. Yang TC, Huang YW, Hu RM, Huang SC, Lin YT.. (2009) AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia., 53 (7): [PMID:19414581] [10.1128/aac.01513-08] |
162. Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T.. (2009) GES-11, a novel integron-associated GES variant in Acinetobacter baumannii., 53 (8): [PMID:19451292] [10.1128/aac.00072-09] |
163. Kotsakis SD, Papagiannitsis CC, Tzelepi E, Tzouvelekis LS, Miriagou V.. (2009) Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase., 53 (8): [PMID:19470510] [10.1128/aac.00219-09] |
164. Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A, Piddock LJ.. (2009) Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni., 53 (8): [PMID:19506058] [10.1128/aac.01655-08] |
165. Espedido BA, Partridge SR, Iredell JR.. (2008) bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia., 52 (8): [PMID:18490506] [10.1128/aac.01634-07] |
166. Bratu S, Landman D, Martin DA, Georgescu C, Quale J.. (2008) Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City., 52 (9): [PMID:18591275] [10.1128/aac.01684-07] |
167. Schmidtke AJ, Hanson ND.. (2008) Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa., 52 (11): [PMID:18779353] [10.1128/aac.00341-08] |
168. Papagiannitsis CC, Tzouvelekis LS, Miriagou V.. (2009) Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter., 53 (1): [PMID:19001114] [10.1128/aac.00912-08] |
169. Mulet X, Maciá MD, Mena A, Juan C, Pérez JL, Oliver A.. (2009) Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants., 53 (4): [PMID:19188376] [10.1128/aac.01264-08] |
170. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y.. (2010) Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008., 54 (6): [PMID:20231393] [10.1128/aac.01359-09] |
171. García-Fernández A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, Carattoli A.. (2010) An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant., 54 (10): [PMID:20660683] [10.1128/aac.01301-09] |
172. Girlich D, Poirel L, Nordmann P.. (2010) PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila., 54 (4): [PMID:20145085] [10.1128/aac.01585-09] |
173. Borgianni L, Vandenameele J, Matagne A, Bini L, Bonomo RA, Frère JM, Rossolini GM, Docquier JD.. (2010) Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding., 54 (8): [PMID:20498317] [10.1128/aac.01336-09] |
174. Zamorano L, Reeve TM, Deng L, Juan C, Moyá B, Cabot G, Vocadlo DJ, Mark BL, Oliver A.. (2010) NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa., 54 (9): [PMID:20566764] [10.1128/aac.00385-10] |
175. Kotsakis SD, Miriagou V, Tzelepi E, Tzouvelekis LS.. (2010) Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases., 54 (11): [PMID:20696873] [10.1128/aac.00771-10] |
176. Buvens G, Bogaerts P, Glupczynski Y, Lauwers S, Piérard D.. (2010) Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26., 54 (11): [PMID:20733038] [10.1128/aac.00551-10] |
177. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P.. (2010) Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia., 54 (11): [PMID:20823289] [10.1128/aac.00878-10] |
178. Suh B, Bae IK, Kim J, Jeong SH, Yong D, Lee K.. (2010) Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss., 54 (12): [PMID:20876374] [10.1128/aac.00768-10] |
179. Borgianni L, Prandi S, Salden L, Santella G, Hanson ND, Rossolini GM, Docquier JD.. (2011) Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States., 55 (1): [PMID:21041509] [10.1128/aac.00858-10] |
180. Shimizu-Ibuka A, Oishi M, Yamada S, Ishii Y, Mura K, Sakai H, Matsuzawa H.. (2011) Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1., 55 (1): [PMID:21078949] [10.1128/aac.00098-10] |
181. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
182. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
183. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
184. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
185. Unpublished dataset, |
186. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
187. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
188. Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG.. (2012) Potent inhibitors of LpxC for the treatment of Gram-negative infections., 55 (2): [PMID:22175825] [10.1021/jm2014748] |
189. Flanagan ME, Brickner SJ, Lall M, Casavant J, Deschenes L, Finegan SM, George DM, Granskog K, Hardink JR, Huband MD, Hoang T, Lamb L, Marra A, Mitton-Fry M, Mueller JP, Mullins LM, Noe MC, O'Donnell JP, Pattavina D, Penzien JB, Schuff BP, Sun J, Whipple DA, Young J, Gootz TD.. (2011) Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols., 2 (5): [PMID:24900319] [10.1021/ml200012f] |
190. Montgomery JI, Brown MF, Reilly U, Price LM, Abramite JA, Arcari J, Barham R, Che Y, Chen JM, Chung SW, Collantes EM, Desbonnet C, Doroski M, Doty J, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, McAllister L, McElroy E, Menard CA, Mitton-Fry M, Mullins L, Noe MC, O'Donnell J, Oliver R, Penzien J, Plummer M, Shanmugasundaram V, Thoma C, Tomaras AP, Uccello DP, Vaz A, Wishka DG.. (2012) Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections., 55 (4): [PMID:22257165] [10.1021/jm2014875] |
191. Sarkar A, Anderson KC, Kellogg GE.. (2012) Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics., 52 [PMID:22483632] [10.1016/j.ejmech.2012.03.008] |
192. Mitton-Fry MJ, Arcari JT, Brown MF, Casavant JM, Finegan SM, Flanagan ME, Gao H, George DM, Gerstenberger BS, Han S, Hardink JR, Harris TM, Hoang T, Huband MD, Irvine R, Lall MS, Megan Lemmon M, Li C, Lin J, McCurdy SP, Mueller JP, Mullins L, Niosi M, Noe MC, Pattavina D, Penzien J, Plummer MS, Risley H, Schuff BP, Shanmugasundaram V, Starr JT, Sun J, Winton J, Young JA.. (2012) Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections., 22 (18): [PMID:22892121] [10.1016/j.bmcl.2012.07.005] |
193. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
194. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
195. Brown MF, Mitton-Fry MJ, Arcari JT, Barham R, Casavant J, Gerstenberger BS, Han S, Hardink JR, Harris TM, Hoang T, Huband MD, Lall MS, Lemmon MM, Li C, Lin J, McCurdy SP, McElroy E, McPherson C, Marr ES, Mueller JP, Mullins L, Nikitenko AA, Noe MC, Penzien J, Plummer MS, Schuff BP, Shanmugasundaram V, Starr JT, Sun J, Tomaras A, Young JA, Zaniewski RP.. (2013) Pyridone-conjugated monobactam antibiotics with gram-negative activity., 56 (13): [PMID:23755848] [10.1021/jm400560z] |
196. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
197. Starr J, Brown MF, Aschenbrenner L, Caspers N, Che Y, Gerstenberger BS, Huband M, Knafels JD, Lemmon MM, Li C, McCurdy SP, McElroy E, Rauckhorst MR, Tomaras AP, Young JA, Zaniewski RP, Shanmugasundaram V, Han S.. (2014) Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria., 57 (9): [PMID:24694215] [10.1021/jm500219c] |
198. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
199. Murphy-Benenato KE, Bhagunde PR, Chen A, Davis HE, Durand-Réville TF, Ehmann DE, Galullo V, Harris JJ, Hatoum-Mokdad H, Jahić H, Kim A, Manjunatha MR, Manyak EL, Mueller J, Patey S, Quiroga O, Rooney M, Sha L, Shapiro AB, Sylvester M, Tan B, Tsai AS, Uria-Nickelsen M, Wu Y, Zambrowski M, Zhao SX.. (2015) Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model., 58 (5): [PMID:25658376] [10.1021/jm501506f] |
200. Wolman AT, Gionfriddo MR, Heindel GA, Mukhija P, Witkowski S, Bommareddy A, Vanwert AL.. (2013) Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics., 41 (4): [PMID:23344796] [10.1124/dmd.112.049569] |
201. Murphy-Benenato KE, Dangel B, Davis HE, Durand-Réville TF, Ferguson AD, Gao N, Jahić H, Mueller JP, Manyak EL, Quiroga O, Rooney M, Sha L, Sylvester M, Wu F, Zambrowski M, Zhao SX.. (2015) SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3., 6 (5): [PMID:26005529] [10.1021/acsmedchemlett.5b00026] |
202. Ebrahimi HP, Hadi JS, Almayah AA, Bolandnazar Z, Swadi AG, Ebrahimi A.. (2016) Metal-based biologically active azoles and β-lactams derived from sulfa drugs., 24 (5): [PMID:26833242] [10.1016/j.bmc.2016.01.041] |
203. Fu HG, Hu XX, Li CR, Li YH, Wang YX, Jiang JD, Bi CW, Tang S, You XF, Song DQ.. (2016) Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria., 110 [PMID:26827160] [10.1016/j.ejmech.2016.01.024] |
204. WHO Anatomical Therapeutic Chemical Classification, |
205. British National Formulary (72nd edition), |
206. Faulkner KC, Hurley KA, Weibel DB.. (2016) 5-Alkyloxytryptamines are membrane-targeting, broad-spectrum antibiotics., 26 (22): [PMID:27765507] [10.1016/j.bmcl.2016.10.004] |
207. DrugMatrix, [10.6019/CHEMBL3885881] |
208. Tan L, Tao Y, Wang T, Zou F, Zhang S, Kou Q, Niu A, Chen Q, Chu W, Chen X, Wang H, Yang Y.. (2017) Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections., 60 (7): [PMID:28287720] [10.1021/acs.jmedchem.6b01261] |
209. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
210. Carosso S, Liu R, Miller PA, Hecker SJ, Glinka T, Miller MJ.. (2017) Methodology for Monobactam Diversification: Syntheses and Studies of 4-Thiomethyl Substituted β-Lactams with Activity against Gram-Negative Bacteria, Including Carbapenemase Producing Acinetobacter baumannii., 60 (21): [PMID:28994597] [10.1021/acs.jmedchem.7b01164] |
211. Kou Q, Wang T, Zou F, Zhang S, Chen Q, Yang Y.. (2018) Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria., 151 [PMID:29605810] [10.1016/j.ejmech.2018.03.058] |
212. Reck F, Bermingham A, Blais J, Capka V, Cariaga T, Casarez A, Colvin R, Dean CR, Fekete A, Gong W, Growcott E, Guo H, Jones AK, Li C, Li F, Lin X, Lindvall M, Lopez S, McKenney D, Metzger L, Moser HE, Prathapam R, Rasper D, Rudewicz P, Sethuraman V, Shen X, Shaul J, Simmons RL, Tashiro K, Tang D, Tjandra M, Turner N, Uehara T, Vitt C, Whitebread S, Yifru A, Zang X, Zhu Q.. (2018) Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228., 28 (4): [PMID:29336873] [10.1016/j.bmcl.2018.01.006] |
213. Liu Y, Hu X, Wu Y, Zhang W, Chen X, You X, Hu L.. (2018) Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria., 150 [PMID:29604581] [10.1016/j.ejmech.2018.03.031] |
214. Unpublished dataset, |
215. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
216. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
217. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
218. Gordon EM, Duncton MAJ, Wang BJ, Qi L, Fan D, Li X, Ni ZJ, Ding P, Grygorash R, Low E, Yu G, Sun J.. (2020) Toward Orally Absorbed Prodrugs of the Antibiotic Aztreonam. Design of Novel Prodrugs of Sulfate Containing Drugs. Part 2., 11 (2): [PMID:32071683] [10.1021/acsmedchemlett.9b00534] |
219. Hansen AM, Bonke G, Hogendorf WFJ, Björkling F, Nielsen J, Kongstad KT, Zabicka D, Tomczak M, Urbas M, Nielsen PE, Franzyk H.. (2019) Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae., 168 [PMID:30807888] [10.1016/j.ejmech.2019.02.024] |
220. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
221. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
222. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
223. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
224. Goldberg JA, Nguyen H, Kumar V, Spencer EJ, Hoyer D, Marshall EK, Cmolik A, O'Shea M, Marshall SH, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Bethel CR, Papp-Wallace KM, Logan LK, Perez F, Jacobs MR, van Duin D, Kreiswirth BM, Bonomo RA, Plummer MS, van den Akker F.. (2020) A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli., 63 (11): [PMID:32420736] [10.1021/acs.jmedchem.0c00255] |
225. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
226. Lima LM,Silva BNMD,Barbosa G,Barreiro EJ. (2020) β-lactam antibiotics: An overview from a medicinal chemistry perspective., 208 [PMID:33002736] [10.1016/j.ejmech.2020.112829] |
227. Thu ZM,Sun J,Ji J,He L,Ji J,Iqbal Z,Myo KK,Gao Y,Zhai L,Mu Y,Tang D,Vidari G,Yang H,Yang Z. (2021) Synthesis and antibacterial evaluation of new monobactams., 39 [PMID:33636305] [10.1016/j.bmcl.2021.127878] |
228. Goldberg JA, Kumar V, Spencer EJ, Hoyer D, Marshall SH, Hujer AM, Hujer KM, Bethel CR, Papp-Wallace KM, Perez F, Jacobs MR, van Duin D, Kreiswirth BN, van den Akker F, Plummer MS, Bonomo RA.. (2021) A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp., 220 [PMID:33933754] [10.1016/j.ejmech.2021.113436] |
229. Raja Reddy K, Totrov M, Lomovskaya O, Griffith DC, Tarazi Z, Clifton MC, Hecker SJ.. (2022) Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability., 62 [PMID:35358864] [10.1016/j.bmc.2022.116722] |
230. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |